BusinessDay
Nigeria's leading finance and market intelligence news report.

Nigeria’s genomic capacity for drug production grows on major investments

Nigeria’s capacity to generate essential genomic data for pharmaceutical productions that suit the medical needs of Africa’s genetic framework is gaining more impetus on investors’ growing interest in the development of local molecular medicine. Apart from the business side of it, the investments are pushing the common goal of building a robust base of genetic…



Join the BusinessDay Inner Circle to read exclusives and gain insights for N1000/month

Get real time updates directly on you device, subscribe now.

Comments are closed.